Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis

被引：0

作者：

Ramirez Garcia, Felipe Julio ^{[1
]}

Inciarte-Mundo, Jose ^{[2
]}

Cuervo, Andrea ^{[3
]}

Celis, Raquel ^{[3
]}

Ruiz-Esquide, Virginia ^{[3
]}

Castellanos-Moreira, Raul ^{[4
]}

Ponce, Andres ^{[3
]}

Gomez-Puerta, Jose ^{[2
]}

Sanmarti, Raimon ^{[2
]}

Canete, Juan ^{[1
,5
]}

机构：

[1] Hosp Clin Barcelona, Arthrit Unit, Dept Rheumatol, Barcelona, Spain

[2] Hosp Univ Clin Barcelona, Barcelona, Catalonia, Spain

[3] Hosp Clin Barcelona, Barcelona, Spain

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] IDIBAPS, Barcelona, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1756

引用

页数：3

共 47 条

[41] Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
Sofia Ajeganova
Maria Andersson
Kristina Forslind
Inger Gjertsson
Britt-Marie Nyhäll-Wåhlin
Björn Svensson
Ingiäld Hafström
BMC Rheumatology, 7
[42] Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
Ajeganova, Sofia
Andersson, Maria
Forslind, Kristina
Gjertsson, Inger
Nyhall-Wahlin, Britt-Marie
Svensson, Bjorn
Hafstrom, Ingiaeld
BMC RHEUMATOLOGY, 2023, 7 (01)
[43] Sustained improvements in disease activity score 28 (DAS28) and patient (PT)-reported outcomes (PRO) with abatacept (ABA) in rheumatoid arthritis (RA) pts with an inadequate response to anti-TNF therapy: The long-term extension (LTE) of the attain trial
Sibilia, J.
Schiff, M.
Genovese, M. C.
Becker, J. P.
Li, T.
McCann, T.
Dougados, M.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 501 - 501
[44] APREMILAST IS ASSOCIATED WITH LONG-TERM (4-YEAR) DAS-28 (CRP) REMISSION AND IMPROVEMENTS IN SKIN DISEASE: RESULTS FROM A PHASE III STUDY IN DMARD/BIOLOGIC-EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Edwards, C. J.
Blanco, F. J.
Crowley, J.
McIlraith, M.
Paris, M.
Delev, N.
Teng, L.
Birbara, C. A.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 672 - 672
[45] Is the Self-Assessment of Disease Activity (auto-DAS28) By Patients a Feasible and Acceptable Measure over the Long Term in Rheumatoid Arthritis (RA)? Three-Year Follow-up of a Nurse-Led Program in 771 Patients with Established RA
Gossec, Laure
Foissac, Frantz
Soubrier, Martin
Molto, Anna
Fayet, Francoise
Bardin, Thomas
Berenbaum, Francis
Cantagrel, A.
Cerato, Marie Helene
Chales, Gerard H.
Chary-Valckenaere, Isabelle
Combe, Bernard
Labous, Emmanuelle Dernis
Euller-Ziegler, Liana
Flipo, Rene-Marc
Gaudin, Philippe
Gilson, Melanie
Guis, Sandrine
Mariette, Xavier
Mouterde, Gael
Pouplin, Sophie
Richette, Pascal
Saraux, Alain
Schaeverbeke, Thierry
Sibilia, Jean
Dougados, Maxime
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[46] IS THE SELF-ASSESSMENT OF DISEASE ACTIVITY (AUTO-DAS28) BY PATIENTS A FEASIBLE AND ACCEPTABLE MEASURE OVER THE LONG TERM IN RHEUMATOID ARTHRITIS (RA)? THREE-YEAR FOLLOW-UP OF A NURSE-LED PROGRAM IN 771 PATIENTS WITH ESTABLISHED RA
Gossec, L.
Molto, A.
Foissac, F.
Soubrier, M.
Fayet, F.
Gaudin, P.
Dougados, M.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1250 - 1250
[47] Sustained efficacy along with improvements in disease activity score 28 (DAS 28) and patient (Pt)-reported outcomes (PROs) with abatacept (Aba) in rheumatoid arthritis (RA) pts with an inadequate response to anti-tumor necrosis factor (TNF) therapy: The long-term extension (LTE) of the attain trial
Dougados, M.
Schiff, M.
Luggen, M.
Becker, J. C.
Aranda, R.
Li, T.
McCann, T.
Schmidely, N.
LeBars, M.
Sibilia, J.
Genovese, M. C.
RHEUMATOLOGY, 2007, 46 : I99 - I99

← 1 2 3 4 5 →